Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gelber

Showing results (141-150 of 395) with videos related to

Pageof 40
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemiaSteven E Lipshultz, Stuart R Lipsitz, Stephen E Sallan, et al.
Statistics in Medicine|April 29, 1998
Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing dataJ Bernhard, H F Peterson, A S Coates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study GroupC Hürny, J Bernhard, A Coates, et al.
Journal of the National Cancer Institute. Monographs|January 5, 2002
Adjuvant therapy for very young women with breast cancer: need for tailored treatmentsA Goldhirsch, R D Gelber, G Yothers, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study GroupC Hürny, J Bernhard, R D Gelber, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2016
Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast Cancer Study Group Trials VI and VIIPer Karlsson, Bernard F Cole, Karen N Price, et al.
JAMA|January 9, 1987
Outcome of pregnancy in survivors of Wilms' tumorF P Li, K Gimbrere, R D Gelber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance. The International Breast Cancer Study Group (formerly Ludwig Group)V Spataro, K Price, A Goldhirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2007
Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93, Marco Colleoni, Shari Gelber, et al.
Journal of the National Cancer Institute|December 18, 2003
Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial, Monica Castiglione-Gertsch, Anne O'Neill, et al.
Pageof 40

Showing results (141-150 of 395) with videos related to

Sort By:
Pageof 40
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemiaSteven E Lipshultz, Stuart R Lipsitz, Stephen E Sallan, et al.
Statistics in Medicine|April 29, 1998
Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing dataJ Bernhard, H F Peterson, A S Coates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study GroupC Hürny, J Bernhard, A Coates, et al.
Journal of the National Cancer Institute. Monographs|January 5, 2002
Adjuvant therapy for very young women with breast cancer: need for tailored treatmentsA Goldhirsch, R D Gelber, G Yothers, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study GroupC Hürny, J Bernhard, R D Gelber, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2016
Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast Cancer Study Group Trials VI and VIIPer Karlsson, Bernard F Cole, Karen N Price, et al.
JAMA|January 9, 1987
Outcome of pregnancy in survivors of Wilms' tumorF P Li, K Gimbrere, R D Gelber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance. The International Breast Cancer Study Group (formerly Ludwig Group)V Spataro, K Price, A Goldhirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2007
Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93, Marco Colleoni, Shari Gelber, et al.
Journal of the National Cancer Institute|December 18, 2003
Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial, Monica Castiglione-Gertsch, Anne O'Neill, et al.
Pageof 40